- Home
- ZENV vs KZR Comparison
ZENV vs KZR Comparison
Compare ZENV & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZENV
- KZR
- Stock Information
- Founded
- ZENV 2005
- KZR 2015
- Country
- ZENV Brazil
- KZR United States
- Employees
- ZENV N/A
- KZR N/A
- Industry
- ZENV Computer Software: Prepackaged Software
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- ZENV Technology
- KZR Health Care
- Exchange
- ZENV Nasdaq
- KZR Nasdaq
- Market Cap
- ZENV 63.3M
- KZR 65.3M
- IPO Year
- ZENV 2021
- KZR 2018
- Fundamental
- Price
- ZENV $1.36
- KZR $7.62
- Analyst Decision
- ZENV
- KZR Hold
- Analyst Count
- ZENV 0
- KZR 2
- Target Price
- ZENV N/A
- KZR $20.00
- AVG Volume (30 Days)
- ZENV 80.7K
- KZR 72.5K
- Earning Date
- ZENV 11-18-2024
- KZR 11-12-2024
- Dividend Yield
- ZENV N/A
- KZR N/A
- EPS Growth
- ZENV N/A
- KZR N/A
- EPS
- ZENV N/A
- KZR N/A
- Revenue
- ZENV $173,594,726.00
- KZR N/A
- Revenue This Year
- ZENV $21.46
- KZR N/A
- Revenue Next Year
- ZENV $9.29
- KZR $66.68
- P/E Ratio
- ZENV N/A
- KZR N/A
- Revenue Growth
- ZENV 23.49
- KZR N/A
- 52 Week Low
- ZENV $0.88
- KZR $5.20
- 52 Week High
- ZENV $3.88
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- ZENV 54.17
- KZR 53.01
- Support Level
- ZENV $1.12
- KZR $7.21
- Resistance Level
- ZENV $1.55
- KZR $7.65
- Average True Range (ATR)
- ZENV 0.12
- KZR 0.26
- MACD
- ZENV 0.02
- KZR -0.01
- Stochastic Oscillator
- ZENV 55.81
- KZR 95.71
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.